Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHansard Regulatory News (HSD)

Share Price Information for Hansard (HSD)

Share Price is delayed by 15 minutes
Get Live Data
51.75    0.00 (0.00%)
Bid:
51.00
Ask:
52.50
Spread: 1.50 (2.941%)
Market Cap: £70.66m
HSD Live PriceLast checked at - London Stock Exchange

Intraday Hansard Share Chart

Dr Leonard Polonsky

17 Mar 2025 07:00

RNS Number : 9021A
Hansard Global plc
17 March 2025
 

17 March 2025

 

Hansard Global plc

(Hansard)

 

Hansard Global plc today announces the death (at the age of 97) of its founder, controlling shareholder (under the Leonard Polonsky Revocable Trust) and President, Dr Leonard Polonsky CBE. Dr Polonsky died on Friday 14th March at his home in New York surrounded by loved ones.

Dr Polonsky began working in financial services in New York in 1955, gaining experience of working in Rome, Frankfurt and Zurich, before establishing Liberty Life Assurance Company Limited in London in 1970. Hansard Global plc, its successor, has been listed on the London Stock Exchange since 2006.

A keen philanthropist, Dr Polonsky's legacy will live on through the Polonsky Foundation, a UK-registered charity which supports higher education, cultural heritage and the arts in the UK, the USA, Israel and Europe.

Dr Polonsky's commitment to giving back was recognised in 2013, when he was named a Commander of the British Empire (CBE) for charitable services by HM Queen Elizabeth II.

Known for his charm and creativity, his tireless enthusiasm for Hansard's business and industry, and his deep interest in Hansard's people, Dr Polonsky lived a remarkably full life, earning the respect and admiration of business colleagues, academics and philanthropic beneficiaries across the world.

The Leonard Polonsky Revocable Trust continues to hold Dr Polonsky's shares in the company and is now the controlling shareholder. This Trust was established in 2018 to provide for the orderly control of the shares in the event of Dr Polonsky's death or incapacity.

Policyholders, advisers, employees and all other key stakeholders of the business are assured that, despite this sad news, Hansard will continue to operate as usual.

The management and staff of Hansard share their deepest condolences with Dr Polonsky's family and friends at this sad time.

 

 

 

This announcement contains inside information for the purposes of the UK version of the market abuse regulation (EU no. 596/2014) as it forms part of UK law by virtue of the European union (withdrawal) act 2018 (UK MAR)

 

 

 

Enquiries:

Hansard Global plc +44 (0) 1624 688000

Thomas Morfett, Group CEO

Hazel Stewart, Company Secretary

Email: Investor-relations@hansard.com

 

 

LEI number: 213800ZJ9F2EA3Q24K05

 

 

Notes to editors:

 

· Hansard Global plc is the holding company of the Hansard group of companies. The Company was listed on the London Stock exchange in December 2006. The Group is a specialist long-term savings provider, based in the Isle of Man.

· The Group offers a range of flexible and tax-efficient investment products within a life assurance policy wrapper, designed to appeal to affluent, international investors.

· The Group utilises a controlled cost distribution model via a network of independent financial advisors and the retail operations of certain financial institutions who provide access to their clients in more than 170 countries. The Group's distribution model is supported by Hansard OnLine, a multi-language internet platform, and is scalable.

· The principal geographic markets in which the Group currently services contract holders and financial advisers are the Middle East & Africa, the Far East and Latin America. These markets are served by Hansard International Limited and Hansard Worldwide Limited.

· Hansard Europe dac previously operated in Western Europe but closed to new business with effect from 30 June 2013.

· The Group's objective is to grow by attracting new business and positioning itself to adapt rapidly to market trends and conditions. The scalability and flexibility of the Group's operations allow it to enter or develop new geographic markets and exploit growth opportunities withing existing markets without the need for significant further investment.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUWGWUPAUQM
Date   Source Headline
2nd Jan 20144:35 pmRNSPrice Monitoring Extension
20th Dec 20134:35 pmRNSPrice Monitoring Extension
17th Dec 20134:40 pmRNSSecond Price Monitoring Extn
17th Dec 20134:35 pmRNSPrice Monitoring Extension
4th Dec 201311:31 amRNSDirectorate Change
8th Nov 20137:00 amRNSInterim Management Statement
7th Nov 201312:10 pmRNSAGM Statement
23rd Oct 20134:31 pmRNSBlocklisting Interim Review
26th Sep 201311:59 amRNSDirectorate Change
26th Sep 20137:00 amRNSResults for the year ended 30 June 2013
16th Sep 20132:12 pmRNSDirectorate Change
26th Jul 20137:00 amRNSNew business results
17th Jul 20139:42 amRNSDirector/PDMR Shareholding
26th Jun 20134:00 pmRNSDirectorate Change
21st Jun 20137:00 amRNSSettlement of legal claim in Norway
10th Jun 201311:51 amRNSDirector/PDMR Shareholding
10th Jun 201311:50 amRNSDirector/PDMR Shareholding
22nd May 20132:03 pmRNSDirector/PDMR Shareholding
9th May 20137:00 amRNSInterim Management Statement
23rd Apr 20139:22 amRNSBlocklisting Interim Review
22nd Mar 20139:15 amRNSDate of Interim Management Statement
21st Mar 20133:44 pmRNSDirector/PDMR Shareholding
28th Feb 20137:00 amRNSHalf Yearly Report
29th Jan 20137:00 amRNSNew business results
4th Jan 20137:00 amRNSDirectorate Change
14th Nov 20123:05 pmRNSAGM Statement
13th Nov 201211:25 amRNSDirector/PDMR Shareholding
9th Nov 20127:00 amRNSInterim Management Statement
23rd Oct 201210:52 amRNSBlocklisting Interim Review
2nd Oct 20121:52 pmRNSDirector/PDMR Shareholding
25th Sep 201211:00 amRNSDirector/PDMR Shareholding
24th Sep 20129:15 amRNSDirectorate Change
21st Sep 201211:36 amRNSDirector/PDMR Shareholding
21st Sep 201211:23 amRNSDirector/PDMR Shareholding
21st Sep 20127:00 amRNSFinal Results
31st Jul 20127:00 amRNSNew Business Figures
10th May 20127:00 amRNSInterim Management Statement
1st May 20122:49 pmRNSDirector/PDMR Shareholding
23rd Apr 201211:09 amRNSBlocklisting Interim Review
23rd Feb 201212:10 pmRNSDirector/PDMR Shareholding
23rd Feb 201212:05 pmRNSDirector/PDMR Shareholding
23rd Feb 20127:00 amRNSHalf Yearly Report
31st Jan 20127:00 amRNSNew Business Results
17th Jan 201210:17 amRNSHolding(s) in Company
3rd Jan 201212:02 pmRNSDirectorate Change
17th Nov 20114:54 pmRNSHolding(s) in Company
17th Nov 20114:28 pmRNSDirector/PDMR Shareholding
17th Nov 20114:28 pmRNSDirector/PDMR Shareholding
16th Nov 20115:06 pmRNSAGM Statement
10th Nov 20117:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.